Xanthine Oxidase and Bioenergetic Function in Volume Overload

黄嘌呤氧化酶和容量超负荷时的生物能功能

基本信息

项目摘要

DESCRIPTION (provided by applicant): Volume overload (VO) in the heart promotes bioenergetic, structural, and functional changes that lead to heart failure. However, the mechanisms of myocardial decompensation and the resulting progression to failure due to VO remain unclear. It is established that VO increases xanthine oxidase (XO) and reactive oxygen and nitrogen species (ROS/RNS). In this proposal we will integrate two critical basic research findings in the context of cardiac failure due to VO: 1) XO as a source of oxidative damage in the heart due to VO and 2) the central role mitochondrial dysfunction in the etiology of VO-mediated heart failure. This concept will be tested through pursuit of the following specific aims in targeted animal and human studies. Aim 1 will test the hypothesis that increased XO activity in VO causes LV dysfunction through cardiomyocyte mitochondrial dysfunction in chronic VO in rat. Aim 2 will test the hypothesis that cardiomyocyte-derived XO activity is responsible for cardiomyocyte MMP activation and mitochondrial dysfunction using gene therapy to knockdown XDH in acute and chronic VO in rats. Aim 3 will test the hypothesis that XO inhibition reduces cardiomyocyte oxidative stress and mitochondrial dysfunction and improves LV function after closure of chronic ACF in rat. These experiments will utilize novel gene therapy techniques in rats to prove cause and effect of XO in cardiomyocytes. Studies of cardiomyocyte mitochondrial function will be performed using Seahorse XF24 in animal cells. The animal and cardiomyocyte studies proposed will determine whether increased XO is a key regulator of oxidative stress and mitochondrial dysfunction in the chronic stretch of a pure VO. These studies, if positive, could provide the scientific impetus for a clinical trial of XO inhibition in patients with isolated VO.
描述(由申请人提供):心脏容量过载(VO)促进生物能量,结构和功能变化,导致心力衰竭。然而,心肌失代偿的机制和由此导致的VO进展到衰竭仍不清楚。结果表明,VO增加了黄嘌呤氧化酶(XO)和活性氧和活性氮(ROS/RNS)。在本提案中,我们将整合VO引起心力衰竭的两个关键基础研究成果:1)XO是VO引起心脏氧化损伤的来源,2)线粒体功能障碍在VO介导的心力衰竭病因学中的核心作用。这一概念将在有针对性的动物和人类研究中通过追求以下具体目标来进行测试。目的1将验证VO中XO活性升高通过心肌细胞线粒体功能障碍导致慢性VO大鼠左室功能障碍的假说。目的2将通过基因治疗降低大鼠急性和慢性VO的XDH,验证心肌细胞来源的XO活性对心肌细胞MMP激活和线粒体功能障碍负责的假设。目的3将验证XO抑制降低大鼠慢性ACF闭合后心肌细胞氧化应激和线粒体功能障碍,改善左室功能的假设。这些实验将利用新的基因治疗技术在大鼠身上证明XO在心肌细胞中的因果关系。心肌细胞线粒体功能的研究将在动物细胞中使用Seahorse XF24进行。提出的动物和心肌细胞研究将确定在纯VO的慢性拉伸中,增加的XO是否是氧化应激和线粒体功能障碍的关键调节因子。如果这些研究结果是阳性的,将为在分离性VO患者中进行XO抑制的临床试验提供科学的推动力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis J. Dell'Italia其他文献

Gene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart
原发性二尖瓣反流心脏代谢紊乱的基因表达和超微结构证据
  • DOI:
    10.1093/ehjopen/oeae034
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mariame Selma Kane;J. X. M. Juncos;S. Manzoor;Maximiliano Grenett;Joo;Betty Pat;Mustafa I Ahmed;Clifton Lewis;James E Davies;Thomas S. Denney;Jonathan McConathy;Louis J. Dell'Italia
  • 通讯作者:
    Louis J. Dell'Italia
Nitric Oxide Synthase Modulates Genes Involved in Hepatic Steatosis, Hepatic Fibrosis and Inflammation
  • DOI:
    10.1016/j.freeradbiomed.2011.10.048
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michelle Smith Johnson;Balu Chacko;Junying Zheng;Louis J. Dell'Italia;Jianhua Zhang;Victor M. Darley-Usmar
  • 通讯作者:
    Victor M. Darley-Usmar
GW27-e0081 Angiotensin type II receptor protects cardiovascular functions at the onset of atherosclerosis in young apolipoprotein E-deficient mouse
  • DOI:
    10.1016/j.jacc.2016.07.663
  • 发表时间:
    2016-10-18
  • 期刊:
  • 影响因子:
  • 作者:
    Li Ming;Nawazish Naqvi;Eiji Yahiro;Eddie W. Bradley;Louis J. Dell'Italia;Ahsan Husain
  • 通讯作者:
    Ahsan Husain
Metabolic Dysfunction in Leukocytes Following Cardiac Surgery
  • DOI:
    10.1016/j.freeradbiomed.2012.10.457
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Philip Kramer;Balu Chacko;Taegyu Choi;Michelle S. Johnson;Saranya Ravi;Louis J. Dell'Italia;Spencer J. Melby;James F. George;Victor M. Darley-Usmar
  • 通讯作者:
    Victor M. Darley-Usmar
INCREASED MYOCARDIAL STRAIN AND TORSION IN COMPENSATED PATHOLOGICAL VERSUS PHYSIOLOGICAL LEFT VENTRICULAR VOLUME OVERLOAD
  • DOI:
    10.1016/s0735-1097(11)60838-3
  • 发表时间:
    2011-04-05
  • 期刊:
  • 影响因子:
  • 作者:
    Himanshu Gupta;Marcas M. Bamman;David C. McGiffin;Thomas S. Denney;Louis J. Dell'Italia
  • 通讯作者:
    Louis J. Dell'Italia

Louis J. Dell'Italia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis J. Dell'Italia', 18)}}的其他基金

Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
  • 批准号:
    10701217
  • 财政年份:
    2023
  • 资助金额:
    $ 34.52万
  • 项目类别:
ShEEP Request for Next Generation High Dimension Flow Cytometer
ShEEP 请求下一代高维流式细胞仪
  • 批准号:
    9796482
  • 财政年份:
    2019
  • 资助金额:
    $ 34.52万
  • 项目类别:
Identifying Approaches to Enhance Bone and Cartilage Regeneration
确定增强骨和软骨再生的方法
  • 批准号:
    10629250
  • 财政年份:
    2017
  • 资助金额:
    $ 34.52万
  • 项目类别:
Pathophysiology of Extracellular Matrix and Desmin Breakdown in Volume Overload Heart
容量超负荷心脏中细胞外基质和结蛋白分解的病理生理学
  • 批准号:
    9236513
  • 财政年份:
    2017
  • 资助金额:
    $ 34.52万
  • 项目类别:
The Chymase Angiotensin-(1-12) Axis in Heart Disease
心脏病中的食糜酶血管紧张素 (1-12) 轴
  • 批准号:
    8811838
  • 财政年份:
    2014
  • 资助金额:
    $ 34.52万
  • 项目类别:
The Chymase Angiotensin-(1-12) Axis in Heart Disease
心脏病中的食糜酶血管紧张素 (1-12) 轴
  • 批准号:
    8967205
  • 财政年份:
    2014
  • 资助金额:
    $ 34.52万
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    8059630
  • 财政年份:
    2010
  • 资助金额:
    $ 34.52万
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    7898471
  • 财政年份:
    2010
  • 资助金额:
    $ 34.52万
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    8235831
  • 财政年份:
    2010
  • 资助金额:
    $ 34.52万
  • 项目类别:
Chymase-Mediated MMP Activation in Ishemia Reperfusion Injury
缺血再灌注损伤中食糜酶介导的 MMP 激活
  • 批准号:
    8195546
  • 财政年份:
    2009
  • 资助金额:
    $ 34.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了